Dabigatran etexilate mesylate

• CAT Number: I005256
• CAS Number: 872728-81-9
• Molecular Formula: C35H45N7O8S
• Molecular Weight: 723.84
• Purity: ≥95%
• Synonyms: ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonate
• Target: Thrombin
• Solubility: 10 mM in DMSO
• Storage: Store at -20°C
• IC50: 4.5 nM (Ki); 10 nM(Thrombin-induced platelet aggregation) [1]
• IUPAC Name: ethyl 3-[[2-[[4-[(Z)-N'-hexoxycarbonylcarbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate;methanesulfonic acid
• InChI: InChI=1S/C34H41N7O5.CH4O3S/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29;1-5(2,3)4/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44);1H3,(H,2,3,4)
• InChIKey: XETBXHPXHHOLOE-UHFFFAOYSA-N
• SMILES: CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N.CS(=O)(=O)O

Dabigatran etexilate mesylate (Cat.No:I005256) is an oral anticoagulant medication used for the prevention of blood clots in conditions such as atrial fibrillation and deep vein thrombosis. It inhibits thrombin, an essential enzyme in the blood clotting process.

Reference

[1]. Wienen W, Stassen JM, Priepke H, In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally activeprodrug, dabigatran etexilate. Thromb Haemost. 2007 Jul;98(1):155-62.
[2]. Kansal AR, Sorensen SV, Gani R, Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients withatrial fibrillation. Heart. 2012 Apr;98(7):573-8.